Chinnery P F, Schon E A
Department of Neurology, The University of Newcastle upon Tyne, Newcastle upon Tyne, UK.
J Neurol Neurosurg Psychiatry. 2003 Sep;74(9):1188-99. doi: 10.1136/jnnp.74.9.1188.
Following the discovery in the early 1960s that mitochondria contain their own DNA (mtDNA), there were two major advances, both in the 1980s: the human mtDNA sequence was published in 1981, and in 1988 the first pathogenic mtDNA mutations were identified. The floodgates were opened, and the 1990s became the decade of the mitochondrial genome. There has been a change of emphasis in the first few years of the new millennium, away from the "magic circle" of mtDNA and back to the nuclear genome. Various nuclear genes have been identified that are fundamentally important for mitochondrial homeostasis, and when these genes are disrupted, they cause autosomally inherited mitochondrial disease. Moreover, mitochondrial dysfunction plays an important role in the pathophysiology of several well established nuclear genetic disorders, such as dominant optic atrophy (mutations in OPA1), Friedreich's ataxia (FRDA), hereditary spastic paraplegia (SPG7), and Wilson's disease (ATP7B). The next major challenge is to define the more subtle interactions between nuclear and mitochondrial genes in health and disease.
20世纪60年代初发现线粒体含有自身的DNA(mtDNA)之后,在20世纪80年代取得了两项重大进展:1981年公布了人类mtDNA序列,1988年鉴定出首批致病性mtDNA突变。闸门被打开,20世纪90年代成为线粒体基因组的十年。在新千年的头几年,重点发生了变化,从mtDNA的“魔法圈”转向了核基因组。已经鉴定出各种对线粒体稳态至关重要的核基因,当这些基因被破坏时,会导致常染色体隐性遗传的线粒体疾病。此外,线粒体功能障碍在几种已确立的核基因疾病的病理生理学中起重要作用,如显性视神经萎缩(OPA1突变)、弗里德赖希共济失调(FRDA)、遗传性痉挛性截瘫(SPG7)和威尔逊病(ATP7B)。下一个主要挑战是确定健康和疾病状态下核基因与线粒体基因之间更微妙的相互作用。